xCT/SLC7A11 Antibody

Skip to product information
1 of 1

Selleck Chemicals

SKU:F0517-20UL

Regular price €169,00 EUR
Regular price Sale price €169,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

The cystine/glutamate antiporter SLC7A11, also known as xCT, facilitates cystine import for glutathione synthesis and antioxidant defense. Overexpressed in many cancers, it promotes tumor growth by suppressing ferroptosis, a lipid peroxidation-induced cell death. The system xc−, a sodium-independent antiporter, exports intracellular glutamate while importing extracellular cystine at a 1:1 ratio. Depending on the literature source, SLC7A11 may also be discussed as xCT/SLC7A11 and xCT.

Reported cellular context includes cell membrane, cell projection, and membrane, which can matter when signal is compared across treatments or changing cell states. Following SLC7A11 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

SLC7A11 is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cell projection, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cell membrane, cell projection, and membrane across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for SLC7A11. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in SLC7A11 reflect biology rather than handling. When interpreting SLC7A11, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep SLC7A11 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
SLC7A11
Research Area:
Cancer
Application:
IP • WB
Reactivity:
Human
Specificity:
xCT/SLC7A11 Antibody [E20L8] recognizes endogenous levels of total xCT/SLC7A11 protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
E20L8
UniProt:
Q9UPY5
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.